HISTORY
The American College of Histocompatibility and Immunogenetics (ACHI) launched on October 1, 2020. The ACHI was designed to combine the previous work of the American Society for Histocompatibility and Immunogenetics (ASHI) Director Training, Review, and Credentialing (DTRC) Committee and the former American Board of Histocompatibility and Immunogenetics (ABHI).
ACHI is affiliated with ASHI, operating as a function of ASHI’s Professional Standards Division to:
While the ACHI functions as an entity of ASHI’s Professional Standards Division, it remains a separate corporation with its own Articles of Incorporation, Bylaws, and Operations Manual.
ACHI is affiliated with ASHI, operating as a function of ASHI’s Professional Standards Division to:
- Evaluate the education, training and experience of doctoral professionals in the field of histocompatibility and immunogenetics for eligibility to take its professional examinations .
- Evaluate all submitted documentation including case portfolios, statements from the mentoring director, and letters of recommendation for all prospective candidate directors and candidate technical supervisors.
- Approve proposed didactic, research, and clinical schedules for individual trainees or detailed plans for permanent director training fellowship programs.
- Evaluate scientific content of continuing educational activities for relevance and quality
- Review submitted applications for non-doctoral candidates to determine appropriate eligibility of CHS, CHT, and CHA candidates.
- Develop and administer professional credentialing exams for doctoral (fellow/formerly diplomate) and non-doctoral (CHS, CHT and CHA) candidates.
- Evaluate and accredit director training programs
While the ACHI functions as an entity of ASHI’s Professional Standards Division, it remains a separate corporation with its own Articles of Incorporation, Bylaws, and Operations Manual.